Vertaling van "informing the public optimally " (Nederlands → Frans) :

manner ●● Informing the public optimally ●● Developing transversality (cooperation across
manner ●● Informing the public optimally ●● Developing transversality (cooperation across

Key factor 2 Informing the public optimally ●● Publicising the FAMHP (Formation - Organisation
Key factor 2 Informing the public optimally ●● Publicising the FAMHP (Formation - Organisation

The optimal scenario for informing the patient with regard to decisions related to reimbursement of products linked to a specific treatment is similar to the previous one but (Figure 8) presents a higher number of respondents choosing “inside the organs” and “at each step”. Only 26% would choose to inform the patient outside the existing organs, and with a stronger preference on informing after the decision is taken.
The optimal scenario for informing the patient with regard to decisions related to reimbursement of products linked to a specific treatment is similar to the previous one but ( Figure 8) presents a higher number of respondents choosing “inside the organs” and “at each step”.

For optimal information flow and the active involvement of all employees, an intranet was launched in October 2007.
For optimal information flow and the active involvement of all employees, an intranet was launched in October 2007.

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

The Ministry of Public Health has, however, requested that a post-consumption follow-up be carried out and that the general public be given detailed information about the product’s adverse effects.
Le Ministère de la Santé a cependant demandé que soit mis en œuvre un suivi post-consommation et une information précise à l’attention du grand public sur les effets indésirables de ce produit.

Public awareness is raised by means of information booklets, press articles, a website, and public events.
Cette sensibilisation se fait grâce à des brochures d’information, un site internet, des articles de presse et des événements publics.

In this age of the internet the speed of the information stream is an increasingly important factor in the eyes of the public and care providers. There is therefore also a need to be able to combine rapid, qualitative information.
In this age of the internet the speed of the information stream is an increasingly important factor in the eyes of the public and care providers. There is therefore also a need to be able to combine rapid, qualitative information.

The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.
The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.